Aarti Pharmalabs Ltd. benchmarking: Performance to industry peers

Financial

	Aarti Pharmalabs	Supriya Lifescience	IOL Chem & Pharma
Operational Metrics
Financials
5 yr Average ROE	9.45 %	23.4 %	8.9 %
5yr average Equity Multiplier	1.39	1.25	1.42
5yr Average Asset Turnover Ratio	0.58	0.68	0.99
5yr Avg Net Profit Margin	8.95 %	25.52 %	6.28 %
Price to Book	2.8	5.42	2.14
P/E	34.06	35.07	28.01
5yr Avg Cash Conversion Cycle	94.46 Days	-10.96 Days	37.81 Days
Inventory Days	94.9 Days	56.1 Days	65.55 Days
Days Receivable	94.46 Days	57.43 Days	86.45 Days
Days Payable	76.47 Days	113.66 Days	100.1 Days
5yr Average Interest Coverage Ratio	12.05	60.74	15.8
5yr Avg ROCE	12.13 %	30.51 %	12.63 %
5yr Avg Operating Profit Margin	15.5 %	36.15 %	10.64 %
5 yr average Debt to Equity	0.16	0.06	0.04
5yr CAGR Net Profit	n/a	8.75 %	-9.63 %
5yr Average Return on Assets	6.11 %	17.81 %	6.27 %
Shareholdings
Promoter Holding	43.08 %	68.3 %	57.48 %
Share Pledged by Promoters	11.03 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.9 %	0.02 %	9.29 %
Change in Mutual Fund Holding (3 Yrs)	-4.31 %	-1.05 %	0.0

	Aarti Pharmalabs	Supriya Lifescience	IOL Chem & Pharma
Product Wise Break-Up	Product Wise Break-Up Xanthine 48.9 API 38.7 CDMO 12.4 Pharmaceuticals 0 API 0 Chemicals 0 Ethyl Acetate 0 Ibuprofen 0 Pantaprazole 0 Clopidogrel 0 Metformin 0	Product Wise Break-Up Chemicals 0 Pharmaceuticals 100.0 Pantaprazole 0 API 0 Xanthine 0 Ethyl Acetate 0 CDMO 0 Ibuprofen 0 Clopidogrel 0 Metformin 0	Product Wise Break-Up Chemicals 43.0 Pharmaceuticals 0 Pantaprazole 0 API 20.0 Xanthine 0 Ethyl Acetate 0 CDMO 0 Ibuprofen 37.0 Clopidogrel 0 Metformin 0
Location Wise Break-Up	Location Wise Break-Up India 45.0 North America 0 LAC 0 Europe 0 Rest of the World 0 Others 55.0	Location Wise Break-Up Europe 38.0 Rest of the World 0 North America 5.0 Latin America 21.0 India 0 Others 36.0	Location Wise Break-Up Europe 0 Rest of the World 24.0 North America 0 LAC 0 India 76.0
Customer Segment	Customer Segment Home and Personal care 100.0	-	-